Seiichi Hayato

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

Kenji Ikeda, Masatoshi Kudo, Seiji Kawazoe et al. · Journal of Gastroenterology · 2016 · 344 citations · Full text

Medicine, Oncology, Pharmacology +15

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga et al. · Clinical Cancer Research · 2015 · 189 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Naomi Kiyota, Martin Schlumberger, Kei Muro et al. · Cancer Science · 2015 · 129 citations · Full text

Medicine, Oncology, Pharmacology +11

Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses

Toshiyuki Tamai, Seiichi Hayato, Seiichiro Hojo et al. · The Journal of Clinical Pharmacology · 2017 · 102 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease

Seiichi Hayato, Osamu Takenaka, Sree Harsha Sreerama Reddy et al. · CPT Pharmacometrics & Systems Pharmacology · 2022 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17